Abstract
Thyroid carcinomas range from the most indolent to the most aggressive human malignancies. A variety of clinical and pathologic factors can be used to help predict behavior and determine appropriate therapy. New molecular biologic techniques show promise in further refining the assessment of prognosis in thyroid cancer patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
